| BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) |
Globe Newswire |
04/22 |
07:30 |
| ASML discloses 2026 AGM results |
Globe Newswire |
04/22 |
07:30 |
| WEBUY GLOBAL LTD. Announces Record-Breaking Performance For the Company at NATAS Fair March 2026 with Over US$3.34 Million in Travel Bookings |
Globe Newswire |
04/22 |
07:30 |
| Viomi Technology Co., Ltd Filed 2025 Annual Report on Form 20-F |
Globe Newswire |
04/22 |
07:30 |
| CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies |
Globe Newswire |
04/22 |
07:30 |
| Lead Service Line Replacement Cost Calculator Featured on United Nations South-South Galaxy Platform |
Globe Newswire |
04/22 |
07:30 |
| Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology |
Globe Newswire |
04/22 |
07:25 |
| Caliber Advances Hyatt Studios Development Platform Across Three High-Growth Markets |
Globe Newswire |
04/22 |
07:15 |
| Growscape Launches Revolutionary EarthSafe Sustainability Platform, Setting New Industry Standard |
Globe Newswire |
04/22 |
07:15 |
| Luminoah Announces FDA Clearance of the Luminoah Flow Enteral Nutrition System, A Brighter Future for Tube Feeding |
Globe Newswire |
04/22 |
07:03 |
| SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026 |
Globe Newswire |
04/22 |
07:00 |
| EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting |
Globe Newswire |
04/22 |
07:00 |
| Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026 |
Globe Newswire |
04/22 |
07:00 |
| Rogers Communications Reports First Quarter 2026 Results |
Globe Newswire |
04/22 |
07:00 |
| Coave Therapeutics to present two posters at ARVO 2026, on first-in-class ligand-conjugated suprachoroidal vector and lead gene therapy program |
Globe Newswire |
04/22 |
07:00 |
| Ocular Therapeutix™ to Host Investor Day on June 17, 2026 |
Globe Newswire |
04/22 |
07:00 |
| Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast |
Globe Newswire |
04/22 |
07:00 |
| Sweet Harvest Foods and Nate’s Hives Awarded Three Recipients of the Inaugural Nate’s Hives Research Grant Program |
Globe Newswire |
04/22 |
07:00 |
| Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat |
Globe Newswire |
04/22 |
07:00 |
| Aurora Mobile's EngageLab Redefines AI-Native Customer Engagement at NexTech Week Tokyo Spring 2026 |
Globe Newswire |
04/22 |
07:00 |
| Coherent Corp. Announces Timing of FY2026 Third Quarter Earnings Release |
Globe Newswire |
04/22 |
07:00 |
| Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting |
Globe Newswire |
04/22 |
07:00 |
| Allpoints Services Names Longtime Homebuilding Executive John Ballard as CRO |
Globe Newswire |
04/22 |
07:00 |
| U.S. Retail Spending Rises in Early Spring, but Underlying Consumer Pressures Signal Caution Ahead, Reports Circana |
Globe Newswire |
04/22 |
07:00 |
| Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease” |
Globe Newswire |
04/22 |
07:00 |
